Results 31 to 40 of about 86,748 (312)

Phase 2 Study of Anti-Human Cytomegalovirus Monoclonal Antibodies for Prophylaxis in Hematopoietic Cell Transplantation. [PDF]

open access: yes, 2020
Human cytomegalovirus (HCMV) can cause significant disease in immunocompromised patients, and treatment options are limited by toxicities. CSJ148 is a combination of two anti-HCMV human monoclonal antibodies (LJP538 and LJP539) that bind to and inhibit ...
Akard, Luke   +22 more
core   +3 more sources

Is There (Still) a Place for Sequential Conditioning?

open access: yesCurrent Oncology
There is still an unmet need for the treatment of high-risk hematological malignancies. To date, allogeneic stem cell transplantation remains the only chance of cure.
Boris Bours, Stavroula Masouridi-Levrat
doaj   +1 more source

Mechanical Conditioning of Greenhouse-grown Transplants [PDF]

open access: yesHortTechnology, 1993
M echanical conditioning is physical stimulation or stress deliberately applied in order to manage plant growth and quality (Latimer, 1991). Mechanical stress applied naturally or under controlled conditions alters growth, thus reducing the mass and size of major plant parts.
Joyce G. Latimer, Reuben B. Beverly
openaire   +1 more source

Syngeneic peripheral blood stem cell transplantation with immunosuppression for hepatitis-associated severe aplastic anemia

open access: yesTurkish Journal of Hematology, 2010
Hepatitis-associated aplastic anemia occurs in up to 10% of all aplastic anemia cases. Syngeneic bone marrow transplantation is rare in patients with severe aplastic anemia and usually requires pre-transplant conditioning to provide engraftment.
Aleksandar Savic   +6 more
doaj   +3 more sources

Cost-effectiveness and clinical outcomes of double versus single cord blood transplantation in adults with acute leukemia in France

open access: yesHaematologica, 2014
Double cord blood transplantation extends the use of cord blood to adults for whom a single unit is not available, but the procedure is limited by its cost.
Myriam Labopin   +22 more
doaj   +1 more source

A case report: high dose melphalan as a conditioning regimen for multiple myeloma induces sinus arrest

open access: yesCardio-Oncology, 2020
High dose melphalan is commonly used as a conditioning regimen for autologous stem cell transplantation in multiple myeloma. There are reports of adverse cardiac events with melphalan manifested by supraventricular tachycardia and atrial fibrillation ...
Liang-Liang Ma   +5 more
doaj   +1 more source

Dose intensity for conditioning in allogeneic hematopoietic cell transplantation: can we recommend “when and for whom” in 2021?

open access: yesHaematologica, 2021
Allogeneic hematopoietic stem-cell transplantation is a potentially curative therapy for various hematologic diseases. An essential component of this procedure is the pre-transplant conditioning regimen, which should facilitate engraftment and reduce or
Nico Gagelmann, Nicolaus Kröger
doaj   +1 more source

Why and When Are Evidence‐Based Interventions Adopted in Paediatric Supportive Care? A Qualitative Exploration of the Determinants of Photobiomodulation Implementation

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Oral mucositis is a common and debilitating side effect of childhood cancer and stem cell transplant treatments. It affects the quality of life of children and young people (CYP) and places a strain on services. Photobiomodulation is recommended for oral mucositis prevention in international guidance but is poorly implemented in UK ...
Claudia Heggie   +4 more
wiley   +1 more source

State-of-the-art review: allogeneic stem cell transplantation for myelofibrosis in 2019

open access: yesHaematologica, 2019
Advances in understanding the pathogenesis and molecular landscape of myelofibrosis have occurred over the last decade. Treating physicians now have access to an ever-evolving armamentarium of novel agents to treat patients, although allogeneic ...
Donal P. McLornan   +5 more
doaj   +1 more source

Posttransplantation Lymphoproliferative Disease Treated by Retransplantation

open access: yesCase Reports in Immunology, 2020
Epstein–Barr virus- (EBV-) induced posttransplantation lymphoproliferative disease (PTLD) is a life-threatening complication following allogeneic stem cell transplantation. The main risk factor is anti-thymocyte globulin (ATG).
Ingerid Weum Abrahamsen   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy